Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
1.650
+0.220 (15.38%)
At close: Mar 9, 2026, 4:00 PM EDT
1.590
-0.060 (-3.64%)
After-hours: Mar 9, 2026, 7:50 PM EDT
Treace Medical Concepts Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -59 | -55.74 | -49.53 | -42.82 | -20.55 | |
| Depreciation & Amortization | 9.62 | 7.42 | 4.85 | 2.13 | 0.69 | |
| Other Amortization | 1.29 | 1.3 | 0.8 | 0.24 | 0.18 | |
| Asset Writedown & Restructuring Costs | - | - | - | 0.35 | - | |
| Loss (Gain) From Sale of Investments | -0.12 | -1.15 | -1.41 | -0.13 | - | |
| Stock-Based Compensation | 33.82 | 30.6 | 17.35 | 8.11 | 3.41 | |
| Provision & Write-off of Bad Debts | 0.83 | 2.95 | 0.43 | 0.41 | 0.14 | |
| Other Operating Activities | 6.17 | 2.89 | 2.67 | 6.86 | -0.07 | |
| Change in Accounts Receivable | -2.09 | -5.69 | -9.3 | -11.04 | -4.23 | |
| Change in Inventory | 3.22 | -10.01 | -9.85 | -8.77 | -2.74 | |
| Change in Accounts Payable | -3.8 | -1.31 | 3.17 | 4.61 | 1.79 | |
| Change in Other Net Operating Assets | -5.92 | -8.42 | 6.24 | 9.39 | 4.19 | |
| Operating Cash Flow | -15.97 | -37.17 | -34.58 | -30.65 | -17.19 | |
| Capital Expenditures | -13.52 | -11.59 | -11.46 | -14.84 | -2.71 | |
| Cash Acquisitions | - | - | -20 | - | - | |
| Investment in Securities | 26.77 | 46.97 | -49.84 | -61.68 | - | |
| Investing Cash Flow | 13.25 | 35.38 | -81.3 | -76.52 | -2.71 | |
| Long-Term Debt Issued | 60.86 | - | - | 53.5 | - | |
| Total Debt Issued | 60.86 | - | - | 53.5 | - | |
| Short-Term Debt Repaid | - | - | - | - | -1.79 | |
| Long-Term Debt Repaid | -57.23 | - | - | -33.89 | - | |
| Total Debt Repaid | -57.23 | - | - | -33.89 | -1.79 | |
| Net Debt Issued (Repaid) | 3.63 | - | - | 19.61 | -1.79 | |
| Issuance of Common Stock | 0.55 | 0.43 | 116.9 | 2.19 | 120.04 | |
| Repurchase of Common Stock | -0.9 | -0.27 | -0.01 | - | - | |
| Other Financing Activities | -1.2 | - | -7.5 | -0.99 | -10.6 | |
| Financing Cash Flow | 2.08 | 0.16 | 109.38 | 20.81 | 107.65 | |
| Net Cash Flow | -0.64 | -1.63 | -6.49 | -86.36 | 87.75 | |
| Free Cash Flow | -29.49 | -48.76 | -46.03 | -45.49 | -19.9 | |
| Free Cash Flow Margin | -13.86% | -23.29% | -24.60% | -32.07% | -21.07% | |
| Free Cash Flow Per Share | -0.47 | -0.79 | -0.76 | -0.82 | -0.41 | |
| Cash Interest Paid | 5 | 4.96 | 5.17 | 4.4 | 3.9 | |
| Levered Free Cash Flow | -10.09 | -30.04 | -33.12 | -37.19 | -12.13 | |
| Unlevered Free Cash Flow | -7.05 | -27.06 | -30.18 | -34.69 | -9.77 | |
| Change in Working Capital | -8.58 | -25.43 | -9.74 | -5.81 | -0.98 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.